MDC Issues Commentary as U.S. Gambling Enters ‘Regulatory Reset’ Following $148 Billion Wagered
Notified -
Globe Newswire2-09-2025, 20:52
Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26